Advertisement
Podcast

Robert S. Rosenson, MD, on Secondary Prevention of ASCVD

03/10/2020

 

In this podcast, Robert S. Rosenson, MD, discusses recent research about secondary prevention of atherosclerotic cardiovascular disease (ASCVD) and the implications of the research for clinical practice.

Robert S. Rosenson, MD, is a professor of medicine at Mount Sinai Heart at the Icahn School of Medicine at Mount Sinai in New York, New York. He is also the section editor of Lipid and Metabolic Disorders at the Journal of the American College of Cardiology and section editor of Lipid Disorders for Up to Date Medicine.

Additional Resources:

  • Colantonio LD, Shannon ED, Orroth KK, et al. Ischemic event rates in very-high-risk adults. J Am Coll Cardiol. 2019;74(20):2496-2507. https://doi.org/10.1016/j.jacc.2019.09.025.
  • Bittner V, Colantonio LD, Dai Y, et al. Association of region and hospital and patient characteristics with use of high-intensity statins after myocardial infarction among Medicare beneficiaries. JAMA Cardiol. 2019;4(9):865-872. https://doi.org/10.1001/jamacardio.2019.2481.
  • Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018;73(24):e285-e350. https://doi.org/10.1016/j.jacc.2018.11.003. 
  • Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk (FOURIER). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01764633. Published February 15, 2018. Updated August 21, 2019. Accessed February 7, 2020. ClinicalTrials.gov Identifier: NCT01764633.
  • ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT01663402. Published March 18, 2019. Updated March 18, 2019. Accessed February 7, 2020. ClinicalTrials.gov Identifier: NCT01663402.
  • Mach F, Baigent C, Catapano AL, et al; ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2019;41(1):111-188. https://doi.org/10.1093/eurheartj/ehz455. 
  • IMPROVE-IT: Examining Outcomes in Subjects With Acute Coronary Syndrome: Vytorin (Ezetimibe/Simvastatin) vs Simvastatin (P04103). ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00202878. Published September 30, 2015. Updated September 21, 2018. Accessed February 7, 2020. ClinicalTrials.gov Identifier: NCT00202878. 
  • Tsimikas S, Karwatowska-Prokopczuk E, Gouni-Berthold I, et al; AKCEA-APO(a)-LRX Study Investigators. New Engl J Med. 2020;382(3):244-255. https://doi.org/10.1056/nejmoa1905239. 

Related Content

Systemic Sclerosis
Systemic Sclerosis
The Gut Microbiome in Systemic Sclerosis
09/22/2022
Elizabeth Volkmann, MD, discusses her research into the association of the gut microbiome with systemic sclerosis, environmental influences on the microbiota, and advances in treating the disease.
09/22/2022
HIV Prevention
HIV Prevention
Daniel R. Kuritzkes, MD, on HIV Resistance After PrEP
10/14/2021
He talks about HIV resistance in the context of pre-exposure prophylaxis use, how common it is, and how PrEP might influence subsequent therapies.
10/14/2021
Inflammatory Bowel Disease
Inflammatory Bowel Disease
David Hudesman, MD, on Shared Decision-Making in IBD Therapy: Ensuring Patients Don't Fail
10/31/2018
Dr David Hudesman from NYU Langone discusses why some patients with IBD fail their medication, how gastroenterologists can approach this, and more.
10/31/2018
Vaccination
Vaccination
HPV Vaccination Rates Among 13- and 15-Year-Olds
02/20/2022
He discusses his latest research that estimated the proportion of adolescents in the United States who are up to date with the HPV vaccine.
02/20/2022
Inflammatory Bowel Disease
Inflammatory Bowel Disease
Benjamin L. Cohen, MD, on IBD and UC: Implementing an Interdisciplinary Approach
10/04/2018
Dr Ben Cohen from Mount Sinai discusses inflammatory bowel disease and vaccination, as well as caring for patients with ulcerative colitis and when surgery is indicated in patients with UC.
10/04/2018